Bisphosphonates are a class of drugs used to treat musculoskeletal disorders, such as osteoporosis, Paget's disease, and bone metastases. They work by inhibiting the activity of osteoclasts, the cells responsible for breaking down bone. Bisphosphonates are typically administered orally or intravenously, and are available in both generic and branded forms. Bisphosphonates are widely used in the treatment of musculoskeletal disorders, and are often prescribed in combination with other drugs. They are generally well-tolerated, with few side effects. However, long-term use of bisphosphonates has been associated with an increased risk of atypical femur fractures. The bisphosphonates market is highly competitive, with a number of major players. These include Merck & Co., Novartis, Amgen, Sanofi, and Pfizer. Other companies in the market include Eli Lilly, GlaxoSmithKline, and Teva Pharmaceuticals. Show Less Read more
ASK A QUESTION
We request your telephone number so we can contact you in the event we have difficulty reaching you via email. We aim to respond to all questions on the same business day.
